Pramipexole and pergolide in the treatment of depression in Parkinson?s disease: a national multicentre prospective randomized study

Abstract

An 8-month multicentre prospective randomized study comparing dopamine receptor agonists pramipexole and pergolide as add-L-dopa therapy on depression in non-demented patients suffering from both mild and moderate depression and PD.

Keywords

• Pramipexole
• pergolide
• treatment
• depression
• Parkinson?s
• disease
• national
• multicentre
• prospective
• randomized
• study